Lauren Wetzler

Benralizumab for <i>PDGFRA</i> -Negative Hypereosinophilic Syndrome

Fei Li Kuang, Fanny Legrand, Michelle Makiya et al. · New England Journal of Medicine · 2019 · 215 citations · Full text

Life Sciences, Immunology, Pathology +10

Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome

Fei Kuang, Michael P. Fay, JeanAnne Ware et al. · The Journal of Allergy and Clinical Immunology In Practice · 2018 · 94 citations

Medicine, Pharmacology, Pharmacotherapy +8

Natural History of Treated Subarachnoid Neurocysticercosis

Theodore E. Nash, Elise M. O’Connell, Dima A. Hammoud et al. · American Journal of Tropical Medicine and Hygiene · 2019 · 80 citations · Full text

Medicine, Neurology, Neurosurgery +11

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Sandhya R. Panch, Michael Bozik, Thomas Brown et al. · Blood · 2018 · 63 citations · Full text

Pharmacy, Pharmacotherapy, Inflammation +6

Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease

Fei Li Kuang, Michelly Sampaio De Melo, Michelle Makiya et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 63 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14